NASDAQ:FMI - Nasdaq - US3504651007
137
+0.2 (+0.15%)
The current stock price of FMI is 137 null. In the past month the price increased by 0.22%. In the past year, price increased by 262.91%.
Foundation Medicine, Inc. provides molecular information products primarily in the United States. The company offers FoundationOne(TM) a molecular information product for the analysis of routine cancer specimens in a clinical setting. Its molecular information platform generates actionable genomic information about a patient's individual disease, enabling physicians to optimize treatments in clinical practice, and enabling biopharmaceutical companies to develop targeted oncology therapies. Foundation Medicine, Inc. is based in Cambridge, Massachusetts.
FOUNDATION MEDICINE INC
150 Second Street
Cambridge MA 02141
CEO: Troy Cox
Phone: 617-418-2200
The current stock price of FMI is 137 null. The price increased by 0.15% in the last trading session.
The exchange symbol of FOUNDATION MEDICINE INC is FMI and it is listed on the Nasdaq exchange.
FMI stock is listed on the Nasdaq exchange.
FOUNDATION MEDICINE INC (FMI) has a market capitalization of 5.09B null. This makes FMI a Mid Cap stock.
FOUNDATION MEDICINE INC (FMI) has a support level at 136.84 and a resistance level at 137.01. Check the full technical report for a detailed analysis of FMI support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
FMI does not pay a dividend.
FOUNDATION MEDICINE INC (FMI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.21).
ChartMill assigns a technical rating of 10 / 10 to FMI. When comparing the yearly performance of all stocks, FMI is one of the better performing stocks in the market, outperforming 99.15% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to FMI. FMI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months FMI reported a non-GAAP Earnings per Share(EPS) of -4.21. The EPS decreased by -38.46% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | -70.28% | ||
ROA | -73.17% | ||
ROE | 1658.26% | ||
Debt/Equity | -12.89 |